You are here

Rituxan

Teva Targets Roche’s Rituxan in Biosimilar Drug Trial

Bloomberg

Tue, 05/25/10 - 08:52 am

Teva Pharmaceuticals

Four Big Areas to Watch at the Upcoming ASCO Meeting, Biotech's Biggest Cancer Confab

BNET Pharma

Mon, 05/24/10 - 08:03 am

personalized medicine

Rituxan, Revlimid win in maintenance trials

Fierce Pharma

Fri, 05/21/10 - 11:26 am

clinical trials

US warns Roche, Shire on misleading drug promotions

Reuters

Thu, 05/6/10 - 08:55 am

Roche Aims to Expand Rituxan Label

Yahoo/Zacks

Sat, 04/10/10 - 11:37 am

follicular lymphoma

Biogen drug OK'd for leukemia treatment

bizjournals.com

Sat, 02/20/10 - 11:01 am

Roche’s Rituxan Gains U.S. Backing for New Cancer Use

Bloomberg

Thu, 02/18/10 - 08:49 pm

Genentech, Biogen Idec get FDA request on application for Rituxan's use in leukemia

Yahoo/AP

Thu, 11/19/09 - 07:52 am

Brain Disease Found in 3rd Patient on Roche’s Rituxan

Bloomberg

Mon, 10/26/09 - 09:41 am

Genentech and Biogen Idec Receive a Complete Response from FDA for Earlier Use of Rituxan for Rheumatoid Arthritis

Businesswire

Mon, 10/19/09 - 07:46 am

rheumatoid arthritis

Rituxan tests positive in Phase III trial

Fierce Pharma

Thu, 09/17/09 - 11:12 am

Spectrum Pharmaceuticals and Zevalin: The Importance of FDA Approval

Seeking Alpha

Mon, 07/20/09 - 08:36 am

Spectrum Pharmaceuticals

Biogen Gains Edge in Drug Talks

WSJ Online

Wed, 06/17/09 - 10:23 am

Genentech, Biogen’s Rituxan Fails Against Lupus

Bloomberg

Thu, 03/12/09 - 10:43 am

Pages